Schwartz, Peter J.
Ackerman, Michael J.
Antzelevitch, Charles
Bezzina, Connie R.
Borggrefe, Martin
Cuneo, Bettina F.
Wilde, Arthur A. M.
Article History
Accepted: 27 May 2020
First Online: 16 July 2020
Competing interests
: M.J.A. is a consultant for Audentes Therapeutics, Boston Scientific, Gilead Sciences, Invitae, Medtronic, MyoKardia and St. Jude Medical, and holds equity/royalties of AliveCor, Blue Ox Health and StemoniX. C.A. is a consultant for Novartis Institutes for BioMedical Research, Inc. and Trevena, Inc. All other authors declare no competing interests.